Loading...
Loading...
Holder clone rankings through .
Among the 1 tracked institutional investors we monitor, CMMB (CHEMOMAB THERAPEUTICS LTD) is held with a combined value of $154.40K across 95,311 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $154.40K. 1 fund increased its holdings.
Total Institutional Value
$154.40K
Total Shares Held
95,311
Institutional Holders
1
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $154.40K | 0.00% | +48.5% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of CMMB with a position worth $154.40K, representing 0.00% of their portfolio. In total, 1 institutional investors hold CMMB with a combined value of $154.40K.
Institutional investors hold $154.40K worth of CMMB stock across 1 positions. The largest institutional holder is CITADEL ADVISORS LLC with $154.40K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CMMB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
| — |
| 5.2% |
| 2026-08-13 |
| — | 1.2% | 2026-08-10 |
SEC Schedule 13D (activist) and 13G (passive) filings for CMMB. Filed when an investor acquires 5%+ ownership.
Last Close
$1.08
2026-10-22
YTD
-39.7%
0% of 52-week range